ABSTRACT
This Viewpoint describes barriers to comprehensive dementia care and proposes strategies for overcoming them.
Subject(s)
Dementia , Humans , Dementia/diagnosis , Dementia/therapyABSTRACT
A health care leader shares her story of living with major depression and calls for better treatments.
Subject(s)
Depression , Depressive Disorder , Depression/therapy , Female , HumansABSTRACT
The experience of Group Health Associates, a multispecialty practice physician group in Cincinnati, Ohio, offers an important case study of how payment incentives and market realities can change the way physicians practice medicine. After nearly thirty years as a capitation-based medical group, these physicians recently switched completely to fee-for-service reimbursement-not willingly, but in response to an evolving marketplace. Their new business strategy seeks to create a case for being paid for performance and treating the chronically ill.
Subject(s)
Capitation Fee , Fee-for-Service Plans , Group Practice/organization & administration , Group Practice/economics , Humans , Ohio , Organizational Case Studies , Organizational Innovation , Physician Incentive PlansABSTRACT
This paper describes the voluntary chronic care improvement program under traditional fee-for-service Medicare as authorized by the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 (Public Law 108-173; section 721). This brief analyzes the emerging issues raised by this new program, including which chronic conditions and regional areas will be targeted, the types of entities that may participate, the physician's role in care management, and the adoption and use of health information technology and evidence-based clinical guidelines.
Subject(s)
Medicare , Pilot Projects , Chronic Disease , Evidence-Based Medicine , Health Expenditures , Humans , Information Management , Insurance, Pharmaceutical Services , Medicare/legislation & jurisprudence , Patient Care Management , Physician's Role , Quality Assurance, Health Care , United StatesABSTRACT
This issue brief describes the characteristics of the population of individuals known as "dual eligibles," who are eligible for health insurance coverage through both Medicare and Medicaid. It also looks at the differences between "full Medicaid" and "supplemental Medicaid" dual eligibles and the ongoing challenges associated with enrollment and eligibility, integration and coordination, and managed care. The paper presents several examples of integrated care programs designed to better serve the dual-eligible population, including the Program of All-Inclusive Care for the Elderly, Evercare, social health maintenance organizations, and state/federal initiatives such as the Wisconsin Partnership Program, Texas STAR+PLUS, and others. Finally, it considers the implications for dual eligibles of the House and Senate Medicare prescription drug proposals.
Subject(s)
Eligibility Determination , Medicaid/organization & administration , Medicare/organization & administration , Aged , Health Policy , Health Status , Humans , Insurance, Pharmaceutical Services , Long-Term Care , Managed Care Programs , Poverty , State Government , United StatesABSTRACT
This issue brief examines the sources of variation in Medicare payment and costs across different geographic areas and different sites of care. It discusses payment policies that address variation in the cost of providing care, such as input price adjustments and special payments to hospitals. It also considers differences due to beneficiaries' health status and physicians' practice patterns. Finally, it explores policy options to address Medicare geographic variation.
Subject(s)
Costs and Cost Analysis , Geography/economics , Medicare/economics , Prospective Payment System/economics , Health Status , Humans , Practice Patterns, Physicians'/economics , United StatesABSTRACT
This issue brief provides an overview of Medicare's coverage gaps and the primary sources of supplemental coverage for Medicare beneficiaries. It focuses particularly on the Medigap market: the effects of standardization, recent premium trends and rating practices, and options for reform. It considers Medigap within the context of Medicare prescription drug proposals and efforts to reform the entire Medicare program.